2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
561
Leukemia
282
Precursor Cell Lymphoblastic Leukemia-Lymphoma
235
Lymphoma
160
Myelodysplastic Syndromes
111
Burkitt Lymphoma
91
Congenital Abnormalities
86
Lymphoma, Non-Hodgkin
85
Leukemia, Monocytic, Acute
84
Leukemia, Myelomonocytic, Acute
82
Lymphoma, Large B-Cell, Diffuse
80
Leukemia, Erythroblastic, Acute
75
Leukemia, Megakaryoblastic, Acute
72
Recurrence
70
Lymphoma, Mantle-Cell
70
Lymphoma, Follicular
49
Hodgkin Disease
44
Leukemia, Myelomonocytic, Chronic
43
Leukemia, Biphenotypic, Acute
43
Lymphoma, Large-Cell, Immunoblastic
37
Blast Crisis
37
Anemia, Refractory, with Excess of Blasts
36
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
35
Leukemia, Lymphocytic, Chronic, B-Cell
33
Myeloproliferative Disorders
30
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
28
Lymphoma, B-Cell, Marginal Zone
24
Leukemia, Myeloid, Chronic-Phase
23
Leukemia, Eosinophilic, Acute
23
Leukemia, Basophilic, Acute
22
Interventions
Doxorubicin
17
Echocardiography
14
Exercise
9
Cyclophosphamide
9
Trastuzumab
8
Dexrazoxane
8
Electrocardiography
7
Razoxane
6
Carvedilol
6
Vincristine
4
Radiotherapy
4
Filgrastim
4
Docetaxel
4
Methotrexate
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
Cisplatin
3
Atorvastatin
3
salicylhydroxamic acid
2
sacubitril and valsartan sodium hydrate drug combination
2
empagliflozin
2
dapagliflozin
2
Tablets
2
Social Determinants of Health
2
Silymarin
2
Prednisone
2
Paclitaxel
2
Neoadjuvant Therapy
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Cytarabine
×
Clear all
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled